Cargando…
TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
SIMPLE SUMMARY: TRAIL is a death ligand cytokine, predominantly used by effector immune cells to kill malignantly transformed cells. Since its discovery, TRAIL has attracted a lot of attention as a promising anticancer drug due to its selective action against cancer cells, promising a safe, low-toxi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600485/ https://www.ncbi.nlm.nih.gov/pubmed/36291908 http://dx.doi.org/10.3390/cancers14205125 |